SMARCA4 and serous adenocarcinoma: In addition to the separate study of SMARCA4 described above, studies have shown that high-grade serous carcinoma (HGSC) cells with a low SMARCA4/high SMARCA2 expression phenotype are highly resistant to carboplatin.